Risk factors for first-year hospital readmission after liver transplantation

Peixian Chen1, Wentao Wang, Lunan Yan

  • 1Departments of aLiver Surgery bDepartment of Vascular Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.

Insights

Hospital readmission after liver transplantation (LT) affects 18% of patients within one year. Identifying risk factors like complications and previous surgery can help reduce rehospitalizations and improve outcomes.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Clinical Outcomes Research

Background:

  • Liver transplantation (LT) is a life-saving procedure, but post-transplant readmissions impact patient outcomes.
  • Understanding readmission patterns is crucial for optimizing post-transplant care and resource allocation.

Purpose of the Study:

  • To determine the incidence of hospital readmission within one year following liver transplantation.
  • To identify risk factors associated with early readmission after LT.
  • To analyze the relationship between post-transplant complications and readmission risk, as well as survival outcomes.

Main Methods:

  • Retrospective review of 890 adult patients undergoing LT between January 1999 and August 2013.
  • Data collected from the Chinese Liver Transplant Registry.
  • Statistical analysis to identify risk factors for readmission and compare survival outcomes.

Main Results:

  • 18.0% of patients (142/890) experienced 165 readmissions within one year post-LT.
  • Significant risk factors for readmission included hepatic malignancy, prior abdominal surgery, and various post-transplant complications (biliary, vascular, rejection, pulmonary, infection).
  • Increased number and severity of complications correlated with higher readmission rates and poorer survival outcomes.

Conclusions:

  • Key risk factors for one-year readmission after LT have been identified.
  • This knowledge can guide strategies to prevent and mitigate rehospitalizations in liver transplant recipients.
  • Reducing readmissions is vital for improving long-term survival and quality of life post-LT.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
765
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
596
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
861
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
820
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
263
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
358